Leveraging the Latest Understanding of Viral Vector Immunogenicity to Better Inform Clinical Strategy

Time: 12:15 pm
day: Day 2 CLINICAL AM

Details:

• Highlighting the latest understanding of viral vector immunogenicity seen in the clinical setting
• Outlining new trends and emerging standards in immune mitigation strategies
• Guidance for clinical assay selection to monitor the humoral and cellular immune response to a gene therapy

Speakers:

Soumi Gupta As the head of the Clinical Immunology at BioMarin, Soumi and her team drive immunogenicity strategy for all INDs, clinical development programs and relevant post-approval Read more